Insider Shareholders with Direct Ownership of Recursion Pharmaceuticals, Inc. (RXRX)
This section provides a comprehensive overview of the insiders with direct ownership of Recursion Pharmaceuticals, Inc. (RXRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
RECURSION PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 0 | 4,265,576 | 13,021,519 $90 Million | 1 |
Dec 07, 2021
Reduced 24.67%
|
|
|
Blake Borgeson
Director |
8,668,974 | 8,306,706 | 7,121,322 $49.2 Million | 66 |
Sep 03, 2024
Reduced 0.16%
|
|
Michael Secora
Chief Financial Officer |
2,271,150 | 1,254,957 | 1,402,131 $9.69 Million | 76 |
Sep 11, 2024
Reduced 1.06%
|
|
Christopher Gibson
Chief Executive Officer |
13,453,970 | 13,884,598 | 762,656 $5.27 Million | 168 |
Sep 05, 2024
Reduced 2.56%
|
|
Tina Marriott Larson
President and COO |
843,411 | 286,055 | 521,138 $3.6 Million | 69 |
Aug 29, 2024
Reduced 1.14%
|
|
Najat Khan
Chief R&D Commercial Officer |
496,972 | 0 | 496,972 $3.43 Million | 1 |
Aug 01, 2024
Added 50.0%
|
|
David J Mauro
Chief Medical Officer |
246,521 | 16,905 | 229,616 $1.59 Million | 5 |
Aug 15, 2024
Reduced 5.8%
|
|
Shafique Virani
Chief Business Officer |
548,564 | 434,505 | 136,748 $944,928 | 51 |
Jan 16, 2024
Reduced 11.63%
|
|
Ramona Doyle
Chief Medical Officer |
121,535 | 1,813 | 121,110 $836,870 | 7 |
May 16, 2022
Reduced 0.68%
|
|
Zavain Dar
Director |
60,355 | 20,141 | 103,996 $718,612 | 12 |
Jul 01, 2024
Added 1.74%
|
|
Dean Y Li
Director |
670,337 | 615,490 | 73,778 $509,805 | 21 |
Jul 01, 2024
Added 2.11%
|
|
Terry Ann Burrell
Director |
194,504 | 249,811 | 71,254 $492,365 | 17 |
Jul 01, 2024
Added 2.52%
|
|
R. Martin Chavez
Director |
66,328 | 6,250 | 60,078 $415,138 | 17 |
Apr 01, 2024
Added 3.22%
|
|
Robert Hershberg
Director |
57,966 | 6,250 | 51,716 $357,357 | 9 |
Jun 03, 2024
Added 20.21%
|
|
Zachary Bogue
Director |
9,187 | 0 | 9,378 $64,801 | 9 |
Jul 03, 2023
Added 13.31%
|